[1]
F. L. Dzannuba, I. L. Hilmi, H. Sudarjat, J. A. Shadrina, and A. K. Affandhy, “Review Article: The Comparison of Effectiveness and Side Effects of Pembrolizumab in Combination with Chemotherapy versus Single Chemotherapy in the Treatment of Non-Small Cell Lung Cancer (NSCLC)”, JPS, vol. 8, no. 2, pp. 1336–1354, Jun. 2025.